Cite

HARVARD Citation

    Vallejo, A. et al. (n.d.). SAT0099 Polypharmacy is associated with an increased risk of adverse outcomes in patients with rheumatoid arthritis. Annals of the rheumatic diseases. p. 806. [Online]. 
  
Back to record